HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical experience with iodine-123-iodophenylpentadecanoic acid.

Abstract
Initial research in dogs and later research in normal volunteers and patients with coronary artery disease indicated that 123I-iodophenylpentadecanoic acid (IPPA) can provide valuable diagnostic information. This agent compared favorably to 201Tl in detecting stenosed coronary arteries and identified reversible lesions with greater frequency. Testing with both 201Tl and IPPA before and after percutaneous transluminal coronary angioplasty produced similar results, supporting the notion that IPPA deserves inclusion among the diagnostic tools used to evaluate coronary heart disease.
AuthorsJ Corbett
JournalJournal of nuclear medicine : official publication, Society of Nuclear Medicine (J Nucl Med) Vol. 35 Issue 4 Suppl Pg. 32S-37S (Apr 1994) ISSN: 0161-5505 [Print] United States
PMID8151410 (Publication Type: Journal Article, Review)
Chemical References
  • Iodine Radioisotopes
  • Iodobenzenes
  • omega-(4-iodophenyl)pentadecanoic acid
Topics
  • Angioplasty, Balloon, Coronary
  • Animals
  • Coronary Disease (diagnostic imaging, therapy)
  • Heart (diagnostic imaging)
  • Humans
  • Iodine Radioisotopes
  • Iodobenzenes
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: